SCHOTT Pharma Expansion Triples U.S. Capacity, Retains 200 Jobs

SCHOTT Pharma
Credit: Commonwealth Media Services

LEBANON, PA — SCHOTT Pharma’s $60 million expansion in Lebanon County will triple the company’s U.S. manufacturing capacity while retaining more than 200 jobs, adding to Pennsylvania’s efforts to grow its pharmaceutical manufacturing and life sciences sectors.

Gov. Josh Shapiro and Department of Community and Economic Development Secretary Rick Siger joined company officials Wednesday for a ribbon-cutting ceremony at the expanded facility in Lebanon.

The investment strengthens SCHOTT Pharma’s U.S. production footprint at a time when pharmaceutical manufacturers are increasing domestic capacity for drug packaging and delivery systems used in injectable medicines.

SCHOTT Pharma, the pharmaceutical division of German manufacturer SCHOTT, operates facilities in Lebanon and Duryea. The company generated an estimated $1.1 billion in global revenue during 2025 and supports more than 350 jobs across Pennsylvania.

READ:  AIRCO Expands Fuel System Production With Pennsylvania Hub

The Lebanon facility has specialized in drug containment systems since 2003, producing glass vials and related packaging products used to transport and protect injectable medications, including cancer treatments.

The expansion comes as Pennsylvania seeks to build on a life sciences industry that state officials value at nearly $50 billion. The sector employs more than 100,000 workers across approximately 3,100 companies and research institutions statewide.

Over the past five years, Pennsylvania-based researchers and companies have secured more than 10,700 life sciences patents, the fourth-highest total among states, according to the governor’s office.

READ:  New Child Care Tax Credit Proposal Could Save Employers Thousands

“SCHOTT Pharma’s expansion will boost our innovation economy and further strengthen the pharmaceutical manufacturing ecosystem here in Pennsylvania,” Siger said during the event.

The project is the latest in a series of life sciences investments announced across Pennsylvania during the past year. State officials cited expansion projects by companies including Johnson & Johnson, Eli Lilly, Eurofins Lancaster Laboratories and B. Braun as evidence of continued growth in the sector.

The Shapiro administration has linked those investments to broader economic development efforts, reporting more than $41 billion in private-sector investment commitments and more than 23,200 new jobs statewide since January 2023.

Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.